Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

The Neurocognitive Bases of Trust in Intellectual Disability

A legfontosabb adatok

Ki végzi
Hospices Civils de Lyon
Hol
Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
112 fő, tervezett
Kezdés
2026. júl. 17.
Várható befejezés
2030. jan.
A vizsgálat típusa
Megfigyeléses, 4 csoport
A vizsgált kezelések
  • Confidence adjustment assessment
  • clinical assessment
  • Cognitive assessment
  • Executive function assessment
  • Sociability assessment
  • Brain MRI (structural and functional)
A regiszteradat frissítve
2026. augusztus 5.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for people with Down syndrome or Fragile X syndrome, aged 13 to 29. It also takes people with typical development as comparison groups, aged 13 to 29 or children aged 3 to 9. It studies how people decide whom to trust.

Életkor
Down syndrome, Fragile X and same-age comparison groups: 13 to 29 years. Younger comparison group: 3 to 9 years.
Nem
All sexes can join.
A betegség stádiuma
Patient groups: Down syndrome (complete trisomy 21) or Fragile X syndrome (full FMR1 mutation). Comparison groups: typical development. All must be native French speakers with French health insurance.
Korábbi kezelés
Comparison groups cannot join if they are taking drugs that affect the brain and nerves.
Biomarker vagy leletérték
Down syndrome: complete trisomy 21 confirmed by karyotype (chromosome test). Fragile X: complete FMR1 mutation with more than 200 CGG repeats by molecular analysis.

A részvétel fő kizáró okai

  • Unable to understand the tasks, or a major brain malformation
  • Uncontrolled epilepsy, major hearing loss or uncorrected vision problems
  • For the MRI part: a reason MRI cannot be done (pacemaker, metal implants, fear of closed spaces) or needing anaesthesia
  • Comparison groups: known neurological or psychiatric disorders, head injury needing hospital stay, or repeating a school year
  • Comparison groups: birth needing newborn intensive care, birth before 35 weeks, or learning disorders needing therapy for more than one year

A regiszter feltételei, szó szerint

Mind a 44 feltétel megnézéseKevesebb

Ki vehet részt

  • Group of Down Syndrom patients
  • Complete chromosomal trisomy of the 21st chromosome confirmed by karyotype analysis
  • Aged 13 to 29 (chronological age)
  • French as their native language
  • Having signed an informed consent form and/or whose legal guardians/patient representatives have signed the informed consent form
  • Affiliated with the French health insurance system (social security) or whose legal guardians are affiliated with the French health insurance system; Group of X-Fragile Syndrome
  • Complete mutation of the FMR1 gene by molecular analysis (more than 200 CGG triplet repeats)
  • Aged between 13 and 29 (chronological age)
  • Native French speakers
  • Having signed an informed consent form and/or whose legal guardians/patient representatives have signed the informed consent form
  • Affiliated with the French health insurance system (social security) or whose legal guardians are affiliated with the French health insurance system; Group of chronological age-matched control
  • Aged between 13 and 29
  • Native French speakers
  • Having signed an informed consent form and/or whose legal guardians/patient representatives have signed the informed consent form
  • Affiliated with the French health insurance system (social security) or whose legal guardians are affiliated with the French health insurance system; Group of mental age-matched control
  • Aged between 3 and 9
  • Native French speakers
  • Whose legal guardians/patient representatives have signed the informed consent form
  • Affiliated with the French health insurance system (social security) or whose legal guardians are affiliated with the French health insurance system

Ki nem vehet részt

  • Ongoing treatment with drugs affecting the central nervous system
  • Uncontrolled epilepsy
  • Significant hearing impairment
  • Uncorrected visual impairment
  • Known acquired neurological disorders, including epilepsy
  • History of head trauma requiring hospitalisation
  • Known psychiatric disorders
  • Significant hearing impairment
  • Uncorrected visual impairment
  • Learning disorders requiring rehabilitation (speech therapy, psychomotor therapy or orthoptics) for more than one year
  • Refusal by the subject and/or those exercising parental authority/the subject's representative to be informed of any abnormalities detected during the MRI; Groups of typical development persons (chronological age-matched and mental age-matched)
  • Subject participating in another interventional study with an exclusion period still ongoing at the time of pre-inclusion; Regarding the neuroimaging (MRI) study (only for chronological age-matched group):
  • Groups of Down Syndrom and X-Fragiles patients
  • Inability to understand tasks
  • Significant brain malformation
  • Refusal of the subject and/or legal guardians/representative of the subject to be informed of any abnormalities detected during the neuropsychological assessment
  • Subject participating in another interventional study with an exclusion period still ongoing at the time of pre-inclusion; Regarding the neuroimaging (MRI) study:
  • Having a contraindication to MRI examination (people using a pacemaker or insulin pump, people with metal prostheses or intracerebral clips, people with metal fragments in their eyes, as well as claustrophobic subjects). A comprehensive list of contraindications is provided in Appendix 5
  • Inability to perform the MRI without anaesthesia
  • Birth complications requiring admission to a neonatal intensive care unit or prematurity of less than 35 weeks
  • Repeating a school year
  • Refusal of the subject and/or legal guardians/representative of the subject to be informed of any abnormalities detected during the neuropsychological assessment
  • Having a contraindication to MRI examination (people using a pacemaker or insulin pump, people with metal prostheses or intracerebral clips, people with metal fragments in their eyes, as well as claustrophobic subjects). A comprehensive list of contraindications is provided in Appendix 5
  • Inability to perform the MRI without anaesthesia
  • Refusal by the subject and/or those exercising parental authority/the subject's representative to be informed of any abnormalities detected during the MRI

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 3 és 29 év között vagy?

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This project studies the neurocognitive basis of trust adjustment in intellectual disability (ID), a source of significant vulnerability for these patients, focusing on two target populations chosen for their specific social characteristics: people with Down syndrome, who are often described as being hypersocial, and people with Fragile X syndrome, who are often characterized by a completely opposite social behaviour profile, with a withdrawn attitude and significant social anxiety.

A teljes eredeti leírásKevesebb

The three different types of mechanisms that contribute to the adjustment of interpersonal trust: affective evaluation, trait attribution, and epistemic evaluation of informants, will be studied. Affective evaluation processes recruit subcortical structures such as the amygdala and assess potential social threats in the environment. The second mechanism for selecting whom to trust consists of forming a representation of a person's dispositions, such as benevolence and competence (also known as traits), and using it to predict that person's future behaviour. Trait attribution processes recruit a cortico-cerebellar network comprising the mPFC, CRUS I and posterior lobule VI. The third mechanism, called epistemic vigilance, allows to adjust our trust in what others communicate to us. This mechanism involves linking the assessment of the reliability of individuals who communicate (based on their benevolence and competence) with the reliability of the communicated information. Epistemic assessment involves frontal areas and areas associated with the representation of mental states in order to enable the evaluation of the truthfulness of the communicated information. All of these mechanisms become functional very early on, before a child's sixth birthday. There are reasons to expect that several of these central mechanisms supporting selective trust will behave atypically in intellectual disability.

A vizsgálat 4 csoportja

  • Down Syndrome patients

    Patients aged 13 to 29 years old with a confirmed diagnosis of Down Syndrome

    Kezelés: Confidence adjustment assessment, clinical assessment, Cognitive assessment, Executive function assessment, Sociability assessment és Brain MRI (structural and functional)

  • Fragile X Syndrome patients

    Patients aged 13 to 29 years old with a confirmed diagnosis of Fragile X Syndrome

    Kezelés: Confidence adjustment assessment, clinical assessment, Cognitive assessment, Executive function assessment, Sociability assessment és Brain MRI (structural and functional)

  • Chronological age-matched controls

    Persons aged 13 to 29 years old with typical development

    Kezelés: Confidence adjustment assessment, clinical assessment, Cognitive assessment, Executive function assessment, Sociability assessment és Brain MRI (structural and functional)

  • Mental age-matched controls

    Persons aged 3 to 9 years old with typical development

    Kezelés: Confidence adjustment assessment, clinical assessment, Cognitive assessment, Executive function assessment és Sociability assessment

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The Neurocognitive Bases of Trust in Intellectual Disability: Affective Evaluation, Trait Attribution, and Epistemic Vigilance
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT07434037: ki vehet részt
A regiszteradat frissítve
2026. augusztus 5.